Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Apoptosis : an International Journal on Programmed Cell Death|February 13, 2007
Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of LivinBoaz Nachmias, Itay Lazar, Meital Elmalech, et al.Cancer Research|October 16, 2003
Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanomaBoaz Nachmias, Yaqoub Ashhab, Vered Bucholtz, et al.Leukemia & Lymphoma|October 16, 2025
First case report of talquetamab use in AL amyloidosisNoa Gross Even-Zohar, Shlomzion Aumann, Adir Shaulov, et al.European Journal of Haematology|December 31, 2024
Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second RemissionAvraham Frisch, Chezi Ganzel, Yishai Ofran, et al.Endocrine|August 6, 2014
Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutationAuryan Szalat, Michal Shahar, Shoshana Shpitzen, et al.Acta Haematologica|August 7, 2022
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid LeukemiaBoaz Nachmias, Svetlana Krichevsky, Dvora Filon, et al.Annals of Hematology|June 13, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective studyRonit Gurion, Dmitri Guz, Meirav Kedmi, et al.Annals of Hematology|June 22, 2022
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysisOfir Wolach, Avraham Frisch, Liat Shargian, et al.Leukemia Research|July 1, 2022
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center studyAvraham Frisch, Shlomzion Aumann, Tsila Zuckerman, et al.Annals of Hematology|June 19, 2023
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort studyTamar Berger, Tzippy Shochat, Shlomzion Aumann, et al.Pageof 6